Two vaccines that specifically target the Omicron variant have been granted “provisional determination” by Australia’s drugs regulator, the first step in a process for getting the vaccines approved for use.
It comes as the BA.4 and BA.5 subvariants of Omicron drive a new wave of cases, prompting premiers to warn of increasing hospitalisations and deaths, and renewed calls to the public to wear masks in crowded indoor spaces.
